Decreasing Interstage Mortality After the Norwood Procedure: A 30-Year Experience
Open Access
- 20 October 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 9 (19)
- https://doi.org/10.1161/JAHA.120.016889
Abstract
Background The superior cavo-pulmonary connection was introduced at our institution in 1988 for infants undergoing surgery for hypoplastic left heart syndrome. Patients with hypoplastic left heart syndrome remain at high risk for mortality in the time period between the Norwood procedure and the superior cavo-pulmonary connection. The primary objectives of this study were to compare interstage mortality across 4 eras and analyze factors that may impact interstage mortality. Methods and Results Patients with hypoplastic left heart syndrome who underwent the Norwood procedure, were discharged from the hospital, and were eligible for superior cavo-pulmonary connection between January 1, 1988, and December 31, 2017, were included. The study period was divided into 4 eras based on changes in operative or medical management. Mortality rates were estimated with 95% CIs. Adjusted and unadjusted logistic regression models were used to identify risk factors for mortality. There were 1111 patients who met the inclusion criteria. Overall, interstage mortality was 120/1111 (10.8%). Interstage mortality was significantly lower in era 4 relative to era 1 (4.6% versus 13.4%;P=0.02) during the time that age at the superior cavo-pulmonary connection was the lowest (135 days;P<0.01) and the interstage monitoring program was introduced. In addition, use of the right ventricle to pulmonary artery shunt was associated with decreased interstage mortality (P=0.02) and was more routinely practiced in era 4. Conclusions During this 30-year experience, the risk of interstage mortality decreased significantly in the most recent era. Factors that coincide with this finding include younger age at superior cavo-pulmonary connection, introduction of an interstage monitoring program, and increased use of the right ventricle to pulmonary artery shunt.This publication has 28 references indexed in Scilit:
- Cause, timing, and location of death in the Single Ventricle Reconstruction trialThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Use of surveillance criteria reduces interstage mortality after the Norwood operation for hypoplastic left heart syndromeEuropean Journal of Cardio-Thoracic Surgery, 2011
- Variation in Interstage Outpatient Care after the Norwood Procedure: A Report from the Joint Council on Congenital Heart Disease National Quality Improvement CollaborativeCongenital Heart Disease, 2011
- A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at Fontan completionThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Risk factors for interstage death after stage 1 reconstruction of hypoplastic left heart syndrome and variantsThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Right Ventricle–to–Pulmonary Artery Conduit Versus Blalock-Taussig Shunt: A Hemodynamic ComparisonThe Annals of Thoracic Surgery, 2006
- Early postoperative outcomes in a series of infants with hypoplastic left heart syndrome undergoing stage I palliation operation with either modified Blalock-Taussig shunt or right ventricle to pulmonary artery conduit*Pediatric Critical Care Medicine, 2006
- Outcomes After the Stage I Reconstruction Comparing the Right Ventricular to Pulmonary Artery Conduit With the Modified Blalock Taussig ShuntThe Annals of Thoracic Surgery, 2005
- Epidemiology of congenital heart disease in the United StatesAmerican Heart Journal, 1994
- Fontan's procedure in two stagesThe American Journal of Surgery, 1993